Held May 18–21 in the Beskydy Mountains (Czech Republic), HPCSE 2026 brought together leading experts in high-performance computing, applied mathematics, AI, and quantum computing under the banner of IT4Innovations National Supercomputing Center.
Paulo Silva from IT4Innovations, partner of AVITHRAPID, attended the conference and presented a poster “Enabling HPC-Accelerated Virtual Screening for Drug Discovery through the LEXIS Platform” at the poster session, promoting the activities of the project.
For AVITHRAPID, the EU Horizon Europe project building a pre-clinical drug discovery pipeline using sophisticated computational methods to rapidly respond to novel viral infections, a venue like HPCSE is strategically vital. Advanced AI and large-scale molecular simulation are central to our approach — precisely the capabilities showcased at the conference.
With 13 plenary speakers from institutions across Europe and the US, HPCSE offered AVITHRAPID partners a rare opportunity to benchmark their computational workflows, explore collaborations, and connect with the supercomputing community that powers their antiviral research.